Identification of the Novel HLA‐DRB1*03:234 Allele by Next‐Generation Sequencing
HLA · 2026-11 · 108 (5)
DOI: 10.1111/tan.71063 ↗Kurz gefasst
Leserbrief in der Zeitschrift HLA, online erschienen am 29.10.2026. Verfasst von Ruby J Siegel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, Arizona, USA. Hauptthemen laut MEDLINE: Alleles, HLA-DRB1 Chains, Exons, High-Throughput Nucleotide Sequencing. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
HLA‐DRB1*03:234 differs from HLA‐DRB1*03:01:01:01 by two adjacent nucleotide substitutions in exon 2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, Arizona, USA.
ORCID-Profile: Ruby J Siegel, Katrin Hacke, Catherine L Gebhart, Brian J Franz, Andrés Jaramillo
Zitieren
APA
Siegel, R. J., Hacke, K., Gebhart, C. L., Franz, B. J., & Jaramillo, A. (2026). Identification of the Novel HLA‐DRB1*03:234 Allele by Next‐Generation Sequencing. HLA, 108(5). https://doi.org/10.1111/tan.71063
Vancouver
Siegel RJ, Hacke K, Gebhart CL, Franz BJ, Jaramillo A. Identification of the Novel HLA‐DRB1*03:234 Allele by Next‐Generation Sequencing. HLA. 2026;108(5). doi:10.1111/tan.71063
BibTeX
@article{Siegel2026,
author = {Siegel, Ruby J and Hacke, Katrin and Gebhart, Catherine L and Franz, Brian J and Jaramillo, Andrés},
title = {Identification of the Novel HLA‐DRB1*03:234 Allele by Next‐Generation Sequencing},
journal = {HLA},
year = {2026},
volume = {108},
number = {5},
doi = {10.1111/tan.71063}
}
EUVIMED